OUR STATEMENT ON COVID-19
About Us
Pipeline
Therapeutic focus
Contact us
Investors
Open
Search
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Videos
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity Matrix
Filing Type:
View All
10-K
10-Q
3
4
4/A
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-8
SC 13D
UPLOAD
Year:
View All
2023
2022
2021
2020
Date
Form
Description
PDF
XBRL
Pages
11/08/22
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
11/08/22
UPLOAD
SEC-generated letter
Documents
expand_more
TEXT-EXTRACT
1
11/02/22
4
Statement of changes in beneficial ownership of securities
1
11/02/22
3
Initial statement of beneficial ownership of securities
Documents
expand_more
EX-24
2
11/02/22
S-1
General form of registration statement for all companies including face-amount certificate companies
Documents
expand_more
EX-5.1
EX-23.1
EX-FILING FEES
15
10/28/22
8-K
Current report filing
2
10/25/22
DEFR14A
Definitive revised proxy soliciting materials
19
10/17/22
DEF 14A
Definitive proxy statements
17
10/13/22
8-K
Current report filing
Documents
expand_more
EX-3.1
12
10/11/22
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
5
rss_feed
Filing RSS
arrow_back
1
2
3
4
5
6
7
8
9
10
…11
arrow_forward
Email Alerts
Contacts
RSS News Feed